Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Fentanyl
Durogesic DTrans
Routinely available
SMC (189/05)
01/10/2007
Indication
Chronic intractable pain due to non-malignant conditions. See link to SMC advice for full details of restriction.
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
Transdermal patches
Comments
October 2007 - New formulation of an existing product already approved for use in chronic intractable pain.